David A. Siegel Alector, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Alector, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 539,500 shares of ALEC stock, worth $2.45 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
539,500
Previous 393,100
37.24%
Holding current value
$2.45 Million
Previous $3.14 Million
3.54%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding ALEC
# of Institutions
161Shares Held
59.8MCall Options Held
67.8KPut Options Held
200-
Black Rock Inc. New York, NY8.48MShares$38.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$22.3 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.06MShares$18.4 Million0.7% of portfolio
-
State Street Corp Boston, MA3.92MShares$17.8 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.77MShares$17.1 Million0.75% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $375M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...